ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,782,417 | -9.7% | 99,299 | +2.2% | 0.01% | -8.3% |
| Q2 2023 | $1,973,970 | -57.2% | 97,192 | -61.6% | 0.01% | -58.6% |
| Q1 2023 | $4,614,428 | +12.9% | 252,984 | +28.0% | 0.03% | +7.4% |
| Q4 2022 | $4,086,368 | -15.2% | 197,600 | +7.3% | 0.03% | -18.2% |
| Q3 2022 | $4,817,000 | +6.8% | 184,134 | +3.4% | 0.03% | +10.0% |
| Q2 2022 | $4,511,000 | -13.0% | 178,014 | +8.3% | 0.03% | +7.1% |
| Q1 2022 | $5,185,000 | -17.7% | 164,303 | +5.6% | 0.03% | -15.2% |
| Q4 2021 | $6,298,000 | -3.0% | 155,619 | -16.4% | 0.03% | -5.7% |
| Q3 2021 | $6,492,000 | +24.8% | 186,178 | -1.7% | 0.04% | +25.0% |
| Q2 2021 | $5,202,000 | -3.6% | 189,454 | -1.4% | 0.03% | -6.7% |
| Q1 2021 | $5,396,000 | +43.5% | 192,150 | +32.7% | 0.03% | +36.4% |
| Q4 2020 | $3,759,000 | +48.2% | 144,787 | -2.2% | 0.02% | +37.5% |
| Q3 2020 | $2,537,000 | -38.6% | 148,004 | -11.3% | 0.02% | -38.5% |
| Q2 2020 | $4,129,000 | +573.6% | 166,889 | +277.7% | 0.03% | +550.0% |
| Q1 2020 | $613,000 | +3505.9% | 44,186 | +2482.5% | 0.00% | – |
| Q4 2019 | $17,000 | +41.7% | 1,711 | +25.9% | 0.00% | – |
| Q3 2019 | $12,000 | +9.1% | 1,359 | -4.7% | 0.00% | – |
| Q2 2019 | $11,000 | – | 1,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |